Recent advances in microtubule-stabilizing agents

YN Cao, LL Zheng, D Wang, XX Liang, F Gao… - European journal of …, 2018 - Elsevier
Highly dynamic mitotic spindle microtubules are superb therapeutic targets for a group of
chemically diverse and clinically successful anticancer drugs. Microtubule-targeted drugs …

Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies

C Ballatore, KR Brunden, DM Huryn, JQ Trojanowski… - 2012 - ACS Publications
The microtubule (MT) associated protein tau, which is highly expressed in the axons of
neurons, is an endogenous MT-stabilizing agent that plays an important role in axonal …

Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities

CC Rohena, SL Mooberry - Natural product reports, 2014 - pubs.rsc.org
Covering: late 2008 to August 2013 Nature has yielded numerous classes of chemically
distinct microtubule stabilizers. Several of these, including paclitaxel (Taxol) and docetaxel …

[HTML][HTML] The binding sites of microtubule-stabilizing agents

JJ Field, JF Díaz, JH Miller - Chemistry & biology, 2013 - cell.com
Microtubules (MTs) are a highly successful target for anticancer therapy. MT-stabilizing
agents (MSAs) bind to MTs, promoting their polymerization, blocking mitosis, and causing …

Microtubule-stabilizing agents: new drug discovery and cancer therapy

Y Zhao, X Mu, G Du - Pharmacology & Therapeutics, 2016 - Elsevier
Microtubule-stabilizing agents (MSAs) have been highly successful in the treatment of
cancer in the past 20 years. To date, three classes of MSAs have entered the clinical trial …

Microtubule-interfering drugs: current and future roles in epithelial ovarian cancer treatment

J Tymon-Rosario, NN Adjei, DM Roque, AD Santin - Cancers, 2021 - mdpi.com
Simple Summary Microtubule-interfering drugs have been used alone or in combination in
the treatment of epithelial ovarian cancer. Over the years and with increasing …

Epothilones: From discovery to clinical trials

S Forli - Current topics in medicinal chemistry, 2014 - ingentaconnect.com
Epothilones are natural compounds isolated from a myxobacterium at the beginning of the
1990s, and showed a remarkable anti-neoplastic activity. They act through the same …

Taccalonolide Binding to Tubulin Imparts Microtubule Stability and Potent In Vivo Activity

AL Risinger, J Li, MJ Bennett, CC Rohena, J Peng… - Cancer research, 2013 - AACR
The taccalonolides are highly acetylated steroids that stabilize cellular microtubules and
overcome multiple mechanisms of taxane resistance. Recently, two potent taccalonolides …

Designing and testing of novel taxanes to probe the highly complex mechanisms by which taxanes bind to microtubules and cause cytotoxicity to cancer cells

M St. George, AT Ayoub, A Banerjee, CDM Churchill… - PLoS …, 2015 - journals.plos.org
Our previous work identified an intermediate binding site for taxanes in the microtubule
nanopore. The goal of this study was to test derivatives of paclitaxel designed to bind to this …

Dictyostatin flexibility bridges conformations in solution and in the β-tubulin taxane binding site

AS Jogalekar, K Damodaran, FH Kriel… - Journal of the …, 2011 - ACS Publications
Dictyostatin (DCT, 1) is a complex, flexible polyketide macrolide that demonstrates potent
microtubule-polymerization activity. Both a solution structure (2a) and a possible binding …